Description: An experimental cancer drug named bevacizumab (trade name Avastin) is the first "anti-angiogenesis" drug to prove that it can shrink tumors and extend survival in patients with metastatic colorectal canceraccording to a national clinical trial

Category: Metastatic Colorectal Cancer

Url: http://www.dukemednews.org/news/article.php?id=6612

Date: Oct 7, 2005

Current Rating: 0.00

Clicks/Hits Received: 0